In this study, we compared the pharmacological and biochemical characteristics of A 2B adenosine receptors in recombinant (hA 2B HEK293 cells) and native cells (neutrophils, lymphocytes) by using a new potent 8-pyrazole xanthine derivative, showing the presence of A 2B mRNA. The rank order of potency of typical adenosine ligands with recombinant hA 2B receptors was consistent with that typically found for interactions with the A 2B subtype and was also similar in peripheral blood cells. 5Ј-N-Ethylcarboxamidoadenosine stimulated cAMP accumulation in both hA 2B HEK293 and native cells, whereas phospholipase C activation was observed in recombinant receptors and endogenous subtypes expressed in neutrophils but not in lymphocytes. MRE 2029-F20 was revealed to be a potent antagonist in counteracting the agonist effect in both signal transduction pathways. In conclusion, [ 3 H]MRE 2029-F20 is a selective and high-affinity radioligand for the hA 2B adenosine subtype and may be used to quantify A 2B endogenous receptors. In this work, we demonstrated their presence and functional coupling in neutrophils and lymphocytes that play a role in inflammatory processes in which A 2B receptors may be involved.
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Adenosine is a ubiquitous modulator that exerts its physiological functions through the interaction with four G protein-coupled receptors classified as A 1 , A 2A , A 2B , and A 3 Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org. doi:10.1124/mol.104.009225.
ABBREVIATIONS:
RT, reverse transcription; PCR, polymerase chain reaction; CGS 21680 2-[p-(2-carboxyethyl)-phenetylamino]-5Ј-N-ethylcarboxamidoadenosine; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; ZM 241385, (4-(2-[7-amino-2-(2-furyl) -[1,2,4]triazolo- [2, 32] [1, 3, 6] triazinyl-amino] ethyl)-phenol); MRS 1754, 8-[4[((4-cyano-[2,6] -phenyl)carbamoylmethyl)oxy)phenyl]-1, OSIP339391, -piperazine-1-carbonyl]-7H-pyrrolo[2, 3-d] pyrimidin-4-ylamino}-ethyl)-acetamide; HEK, human embryonic kidney; MRE 3008-F20, 5-N-(4-methoxyphenyl-carbamoyl)amino-8-propyl-2(2furyl)-pyrazolo- [4,3e-1,2,4-triazolo [1,5-c] pyrimidine; MRE 2029-F20, N-benzo[1,3]dioxol-5-yl-2-[5-(1,3-dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl -(3-iodobenzyl) adenosine-5Ј-N-methyluronamide; CGS 15943, 5-amino-9-chloro-2-(furyl)1,2,4-triazolo [1,5-c] quinazoline; AS 16, 2-(4-benzyloxy-phenyl)-N- [5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl )-1-methyl-1H-pyrazol-3-yl-oxy]-acetamide]; AS 100, N-2,3,4 dichlorophenyl)-2- [5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl (Fredholm et al., 2001; Fredholm, 2003) . In particular, A 2B receptors are associated with stimulation of the adenylate cyclase and activation of phospholipase C through the coupling to Gs and G q/11 proteins, respectively. A 2B receptors have been found on practically every cell in most species. RT-PCR studies revealed their highest expression in cecum, large intestine, and urinary bladder, but lower levels in brain, spinal cord, lung, and vas deferens (Rivkees and Reppert, 1992) . However, besides regulation at the level of gene expression, targeting of the receptor protein to specific cells or tissues is crucial in understanding their role in pathophysiological conditions. The lack of selective pharmacological tools has hampered research in this field; in particular, the lack of selective A 2B receptor agonists has undoubtedly contributed to the general lack of information of their physiological functions. The characterization of A 2B receptors, therefore, often relies on the lack of effectiveness of compounds that are potent and selective agonists of other receptor subtypes. The agonist CGS 21680, for example, has been useful in differentiating between A 2A and A 2B receptors (Feoktistov and Biaggioni, 1995; Fiebich et al., 1996 Fiebich et al., , 1997 . However, pharmacological characterization of receptors based on apparent agonist potencies is far from ideal, because it depends not only on agonist binding to the receptor but also on multiple processes involved in signal transduction . Based on functional assays using novel A 2B selective antagonists, significant progress has been made in the understanding of the molecular pharmacology and physiology of A 2B adenosine receptors. They seem to be implicated in mast-cell secretion , coronary flow regulation (Talukder et al., 2003) , neoangiogenesis (Grant et al., 2001; Feoktistov et al., 2002 Feoktistov et al., , 2003 Afzal et al., 2003) , cytokine release by bronchial smooth muscle cells (Zhong et al., 2004) , and nociception (Abo-Salem et al., 2004) , suggesting a possible role of the A 2B subtype in the modulation of inflammatory processes involved in asthma, tumor growth, tissue injury, ischemia, and pain (Feoktistov et al., 2003; Livingston et al., 2004) .
The characterization of A 2B receptors through radioligand binding studies has been performed, until now, by using low-affinity and nonselective antagonists, such as and 3-(3-[ 125 I ]iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine, that, as a consequence of their low affinity, display a rapid dissociation rate from the receptor. In addition, because these ligands are nonselective, their utility in native systems is hampered because many tissues and cell lines express several adenosine subtypes. Based on these considerations, it is evident that, to obtain more information about the physiological role of A 2B receptors, new radiolabeled compounds with high affinity and selectivity should be synthesized. High-affinity radioligands for A 2B receptors, [
3 H]MRS 1754, and [ 3 H]-OSIP339391 have been introduced (Ji et al., 2001; Stewart et al., 2004 ), but they were not commercially available at the time of this study. Our group has identified a series of 8-pyrazole xanthine derivatives as potent and selective human A 2B adenosine antagonists (Baraldi et al., 2004a,b) , and a radiolabeled form of one compound of this series was used as a new pharmacological tool to describe the comparison between human recombinant A 2B receptors stably transfected in HEK 293 cells (hA 2B HEK 293 cells) and endogenous receptors present in neutrophils and lymphocytes, which represent inflammatory cells potentially involved in the exacerbation of asthma and other inflammatory processes in which A 2B receptors are thought to be involved. In this study, we demonstrated that A 2B receptors are strongly linked to adenylyl cyclase in both transfected and native cells, whereas for phospholipase C activity, they are well coupled in transfected cells, less in neutrophils, and not at all in lymphocytes, where the A 2B expression is quite low. Bioscience from tritium gas by a method developed by Nycomed Amersham plc. The product was purified by reversed-phase highperformance liquid chromatography using an acetonitrile/trifluoroacetic acid gradient (Baraldi et al., 2004a) .
Materials and Methods

Materials
Stable Transfection of HEK 293 Cells. cDNA encoding human A 2B receptors was a gift of Prof. Karl-Norbert Klotz (Institut fü r Pharmakologie und Toxikologie, Universitat Wü rzburg, Wü rzburg, Germany) and subcloned into the expression plasmid pcDNA 3.1 (Invitrogen). The plasmid was amplified into a competent Escherichia coli strain and plasmid DNA isolated by using QIAGEN Maxiprep columns (plasmid purification kit; QIAGEN, Valencia, CA). cDNA was then sequenced on both strands in the University of Padova, DNA Sequence Service CRIBI, and transfected into HEK 293 cells by using the calcium phosphate precipitation method (Chen and Okayama, 1987) . Colonies were selected by growth of cells on 0.8 mg/ml G-418. Stably transfected cells were maintained in Dulbecco's modified Eagle's medium/Ham's F-12 medium (Dulbecco's modified Eagle's medium/F-12 medium) with 10% fetal calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.3 mg/ml G-418, at 37°in 5% CO 2 /95% air.
Membrane Preparation. For membrane preparation, the culture medium was removed. The cells were washed with phosphatebuffered saline and scraped off T75 flasks in ice-cold hypotonic buffer (5 mM Tris HCl and 2 mM EDTA, pH 7.4). The cell suspension was homogenized using a Polytron homogenizer, and the homogenate was spun for 30 min at 36,000g. The membrane pellet was resuspended in 50 mM Tris-HCl buffer, containing 10 mM MgCl 2 , 1 mM EDTA, and 0.1 mM benzamidine, pH 7.4, and incubated with 2 IU/ml adenosine deaminase for 30 min at 37°C. The protein concentration was determined according to a Bio-Rad method (Bradford, 1976) with bovine serum albumin as reference standard.
Peripheral Blood Cells Isolation. Lymphocytes and neutrophils were isolated from buffy coats kindly provided by the Blood Bank of the University Hospital of Ferrara, according to Gessi et al. (2002 Gessi et al. ( , 2004 . In brief, the blood was centrifuged on Ficoll-Hypaque density gradients. The human peripheral blood mononuclear cells were isolated and removed from the Ficoll-Hypaque gradients. Thereafter, they were washed in 0.02 M phosphate-buffered saline at pH 7.2. Further purification of lymphocytes from peripheral blood mononuclear cells was performed by adhesion of monocytes to plastic plates for 2 h at 37°C. To obtain neutrophils, the lower phase of Ficoll-Hypaque gradients was washed and supplemented with 20 ml of 6% Dextran T500. After gentle mixing, erythrocytes were allowed to settle at 20°C for 60 min. The remaining erythrocytes were lysed by suspending the cell pellet in 10 ml of distilled water at 4°C under gentle agitation. After 30 s, isotonicity was restored by adding 3 ml of a solution containing 0.6 M NaCl. Neutrophils were sedimented by centrifugation at 20°C for 20 min at 250g. This procedure resulted in approximately 95% neutrophils, and the cell viability was more than 95% as detected by trypan blue exclusion test. Rat neutrophils and lymphocytes were isolated from male Sprague-Dawley rats (300Ϫ350 g; Stefano Morini, Reggio Emilia, Italy). Blood samples from the inferior vena cava were collected in an EDTA-anticoagulated tube, diluted in phosphate-buffered saline, and isolated by density gradient centrifugation (Ficoll-Hypaque) as described above for human blood cells. Membrane preparations were performed essentially according to Gessi et al. (2002; .
Real-Time RT-PCR Experiments. Total cytoplasmic RNA was extracted from HEK 293 and peripheral blood cells by the acidguanidinium-thiocyanate-phenol method (Chomczynski and Sacchi, 1987) . Quantitative real-time RT-PCR assay (Higuchi et al., 1993) of A 2B mRNA transcript was carried out using gene-specific double fluorescently labeled TaqMan MGB probe (minor groove binder) in an ABI Prism 7700 Sequence Detection System (Applied Biosystems, Warrington Cheshire, UK). For the real-time RT-PCR of the A 2B gene, the assays-on-demand gene expression product (GenBank accession no. NM_0006756) was used with the fluorescent reporter 6-carboxy fluorescein and the quencher 6-carboxy-N,N,NЈ,NЈ-tetramethylrhodamine. For the real-time RT-PCR of the reference gene, the endogenous control human ␤ -actin kits was used, and the probe was fluorescence-labeled with VIC (Applied Biosystems, Monza, Italy). Moreover, a curve of A 2B cDNA plasmid standards with a range spanning at least 6 orders of magnitude (10 Ϫ11 -10 Ϫ16 g/l) was generated. This standard curve displayed a linear relationship between Ct values and the logarithm of plasmid amount. Therefore, quantification of A 2B message in blood cells was made by interpolation from standard curve of Ct values generated from the plasmid dilution series.
Binding Varani et al. (2000) . For the measurement of the association rate, the reaction was terminated at different times (from 5 to 180 min) by rapid filtration under vacuum, followed by washing with 5 ml of ice-cold buffer four times. For the measurement of dissociation rate, the samples were incubated at 4°f or 90 min, and then 1 M MRE 2029-F20 was added to the mixture. The reaction was terminated at different times from 5 to 100 min. (Munson and Rodbard, 1980) was used for computer analysis of saturation and inhibition experiments.
Cyclic AMP Assay. hA 2B HEK-293 and peripheral blood cells were suspended in 0.5 ml of Krebs-Ringer phosphate buffer (KRPG) (136 mM NaCl, 5 mM KCl, 0.67 mM Na 2 HPO 4 , 0.2 mM KH 2 PO 4 , 3 mM NaHCO 3 , 1 mM CaCl 2 , 5 mM glucose, 5 mM HEPES, 10 mM MgCl 2 , and 2.0 IU/ml adenosine deaminase, pH 7.4) containing 0.5 mM 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) as phosphodiesterase inhibitor, and preincubated for 10 min in a shaking bath at 37°C. Then the nonselective adenosine agonist NECA was added to the mixture, and the incubation continued for a further 10 min. The reaction was terminated by the addition of ice-cold 6% trichloroacetic acid. The trichloroacetic acid suspension was centrifuged at 2000g for 10 min at 4°C, and the supernatant was extracted four times with water-saturated diethyl ether. The final aqueous solution was tested for cyclic AMP levels by a competition binding assay carried out essentially according to Varani et al. (1997) . Samples of cyclic AMP standards (0-10 pmol) were added to each test tube containing the incubation buffer (0.1 M Trizma base, 8.0 mM aminophylline, and 6.0 mM 2-mercaptoetanol, pH 7.4) and [ 3 H]cyclic AMP in a total volume of 0.5 ml. The binding protein, previously prepared from beef adrenal glands, was added to the samples and incubated at 4°for 150 min. After the addition of charcoal, samples were centrifuged at 2000g for 10 min. The clear supernatant (0.2 ml) was mixed with 4 ml of Atomlight and counted in a LS-1800 Beckman scintillation counter.
Ins(1,4,5)P 3 Binding Assay. IP 3 generation in hA 2B HEK 293 and peripheral blood cells was measured by [ 3 H]Ins(1,4,5)P 3 competition assay to IP 3 binding protein according to the method described by Challiss et al. (1990) . hA 2B HEK 293 cells (2 ϫ 10 6 cells in each tube) and peripheral blood cells (8 ϫ 10 6 cells in each tube) were suspended in KRPG buffer and stimulated with agonists at 37°C. The reaction was terminated by addition of 0.5 M trichloroacetic acid. Acidified samples were left on ice for 15 min, centrifuged at 3000g for 15 min at 4°C and trichloroacetic acid was extracted with five 2-vol washes with water-saturated diethyl ether. Finally, 125 l of 30 mM EDTA and 125 l of 60 mM NaHCO 3 were added to 500 l of cell extract, and samples were taken for analysis. Buffer samples were also taken through the acidification/extraction protocol to provide diluent for the Ins(1,4,5)P 3 assay standard curve. A 30-l portion of sample or of trichloroacetic acid-extracted buffer containing standard amounts of Ins(1,4,5)P 3 (0.12-12 pmol) or DL-Ins(1,4,5)P 3 (0.3 nmol to define nonspecific binding) was added to 30 l of assay buffer (25 mM Tris HCl and 1 mM EDTA, pH 8) and 30 l of [ 3 H]Ins(1,4,5)P 3 (7000 dpm/assay). Then, 30 l (0.4 mg of protein) of the adrenal-cortical binding protein preparation was added and incubation continued for 30 min. Bound and free [
3 H]Ins(1,4,5)P 3 were separated by rapid filtration through Whatman GF/B glass fiber filters with four 3-ml washes of ice-cold 25 mM Tris HCl, 1 mM EDTA, and 5 mM NaHCO 3 , pH 8. Scintillator was added to the filter discs, and radioactivity was determined after a 12-h extraction period by scintillation counting.
Measurement of Cytosolic Ca 2؉ Concentration. [Ca 2ϩ ] i was evaluated by incubating hA 2B HEK 293 cells with the Ca 2ϩ -sensitive fluorescent dye Fura 2-acetoxymethyl ester (5 M) in KRPG buffer for 45 min at 37°C. Alternate excitation at 340 nM and 380 nM was supplied, and the F 340 /F 380 emission ratio was recorded with a dynamic image analysis system (Laboratory Automation 2.0; RCS, Florence, Italy). For calcium measurements in human lymphocytes and neutrophils, cells were loaded with fura 2-acetoxymethyl ester (2 M) in KRPG buffer, for 30 min at 37°C, according to Gessi et al. (2002) . The cells were centrifuged at 1000g for 10 min to remove receptors was normalized to the expression level of the endogenous reference (␤-actin) in each sample (Fig. 1, A and B) . In addition, the mRNA level of A 2B receptors was investigated in primary cells in which this adenosine subtype is supposed to play an important regulatory role, such as peripheral blood cells. The amount of product was expressed as the ratio of mRNA (determined by interpolation from standard curve of Ct values generated from the plasmid dilution series) and total RNA and indicated the following rank order: monocytes Ͻ lymphocytes Ϸ neutrophils, with monocytes expressing approximately 4-fold less mRNA compared with the other blood cells (Student's t test; *, P Ͻ 0.01 versus monocytes) (Fig. 1C) .
Results
Real
Radioligand Binding Studies in Recombinant and Native Cells. Fig. 2A (Fig. 4A) . The order of potency of the receptor antagonists was: MRE 2029-F20 Ͼ MRS 1754 Ͼ AS 100 Ͼ ZM 241385 Ͼ CGS 15943 Ͼ AS 16 Ͼ DPCPX Ͼ enprofylline Ͼ theophylline (Fig. 4B) (Ji et al., 2001; Stewart et al., 2004) . Saturation experiments of [ 3 H]MRE 2029-F20 binding performed at 21 and 37°C revealed K D values of 3.5 Ϯ 0.4 and 6.5 Ϯ 0.7 nM and B max values of 460 Ϯ 50 and 430 Ϯ 48 fmol/mg of protein, respectively, thus suggesting that dissociation constants increased with temperature, whereas B max data were largely independent of it. This binding behavior has previously been found to be typical of adenosine A 1 , A 2A , and A 3 subtypes (Borea et al., 1996; Varani et al., 2000) . To investigate whether MRE 2029-F20 would be a useful tool to detect A 2B receptors in primary cells, we isolated monocytes, lymphocytes, and neutrophils from peripheral blood. As for human monocytes, it was not possible to detect A 2B receptors, even though the mRNA was present, suggesting that possibly in these cells their level was extremely low. On the other hand, in agreement with real-time RT-PCR experiments, neutrophils and lymphocytes both express A 2B subtype with the following binding parameters: K D of 2.4 Ϯ 0.5 and 2.7 Ϯ 0.7 nM and B max of 79 Ϯ 10 and 54 Ϯ 8 fmol/mg of protein, respectively (Fig. 5, A and B) . The pharmacological profile of selected adenosine agonists and antagonists obtained from inhibition binding experiments in peripheral blood cells revealed a rank order of potency strictly similar to that obtained in transfected cells: NECA Ͼ (R)-PIA Ͼ CHAϾ IB-MECA Ͼ (S)-PIA ϾCGS 21680 and MRE 2029-F20 Ͼ MRS 1754 Ͼ AS100 Ͼ ZM 241385 Ͼ AS16 Ͼ DPCPX Ͼ enprofylline Ͼ theophylline ( (Fig. 6A) . Therefore to evaluate the potency of MRE 2029-F20 at A 2B receptors, a Schild analysis of this compound was performed in the presence of the A 2A blocker, SCH 58261 (100 nM). The pA 2 value of MRE 2029-F20 was 7.81 Ϯ 0.10 nM, in agreement with its affinity in binding experiments performed at 37°C (K D ϭ 6.5 Ϯ 0.7 nM) (Fig. 6B) . In human neutrophils and lymphocytes expressing different adenosine subtypes, the nonselective agonist NECA, through the activation of both A 2A and A 2B receptors, showed EC 50 values of 147 Ϯ 16 and 220 Ϯ 20 nM, respectively. The unstimulated levels of cAMP were 20 Ϯ 5 and 16 Ϯ 4 pmol/10 6 cells and were increased by NECA stimulation to 80 Ϯ 15 and 60 Ϯ 9 in neutrophils and lymphocytes, respectively. To distinguish the role played by the two stimulatory adenosine subtypes, we repeated the concentration-response curve of NECA in the presence of 100 nM Downloaded from MRE 2029-F20 or 100 nM SCH 58261. In the first case, the EC 50 values related to the A 2A component were 39 Ϯ 6 and 70 Ϯ 10 nM in neutrophils and lymphocytes, respectively. In the second condition, the EC 50 values of NECA related to the A 2B receptor stimulation were 2100 Ϯ 220 and 2640 Ϯ 240 nM in neutrophils and lymphocytes, respectively (Fig. 7, A  and B) .
Phosphoinositide Turnover. It is well known that A 2B receptors, in addition to adenylyl cyclase, are also coupled to phospholipase C and stimulate phosphoinositide production. In hA 2B HEK 293 cells, 1 M NECA induced a significant stimulation of IP 3 generation raising from basal values of 1.0 Ϯ 0.3 to 15 Ϯ 2 pmol of IP 3 from 1 ϫ 10 6 cells (P Ͻ 0.01, n ϭ 3). Pretreatment of the cells with 100 nM MRE 2029-F20 and the aminosteroid PLC inhibitor U73122 (5 M) antagonized the NECA-mediated IP 3 generation, suggesting the involvement of A 2B receptors and PLC␤, respectively (Fig.  8A ). When IP 3 generation was evaluated in human lymphocytes, we could not observe any coupling to PLC␤. In contrast, in human neutrophils, it was possible to detect IP 3 turnover induced by classic stimuli linked to PLC activation, such as 10 M formyl-methionyl-leucyl phenylalanine and 100 M NECA. This dose of NECA induced an increase from 0.45 Ϯ 0.15 to 5.94 Ϯ 0.5 pmol of IP 3 from 1 ϫ 10 6 cells that was significantly reduced in the presence of 100 nM MRE 2029-F20 and 5 M U73122 (2.5 Ϯ 0.5 and 0.7 Ϯ 0.2 pmol/10 6 cells, respectively) (P Ͻ 0.01, n ϭ 3) (Fig. 8B) .
Intracellular Calcium Measurements. To better characterize A 2B coupling to PLC activation, intracellular calcium levels were determined. NECA revealed a marked concentration-dependent increase of intracellular Ca 2ϩ in hA 2B HEK 293 cells with an EC 50 value of 312 Ϯ 30 nM (Fig. 9A) . This effect was potently reversed by increasing concentrations of MRE 2029-F20, showing an IC 50 value of 12 Ϯ 2 nM (Fig. 9B) . Treatment with 5 M U73122 completely abrogated NECA-induced calcium increase, whereas no changes in calcium levels were observed in the presence of pertussis toxin that inactivate Gi and Go family G proteins (Fig. 9C ). These data suggest that A 2B receptors in hA 2B HEK 293 cells signal through the activation of Gq /11 protein and PLC␤ enzyme. To investigate the coupling of A 2B receptors with this pathway also in native cells, we performed the same experiments in human lymphocytes and neutrophils. Consistent with IP 3 assay, in human lymphocytes, A 2B receptors did not seem to stimulate intracellular calcium levels. As for human neutrophils, we observed that 100 M NECA increases intracellular calcium levels (Fig. 10A ). This effect was antagonized by MRE 2029-F20 with an IC 50 value of 125 Ϯ 23 nM and completely abrogated in the presence of the PLC inhibitor (Fig. 10, A and B) .
Discussion
In this work, we have compared the pharmacological behavior and the functional coupling of recombinant A 2B adenosine receptors expressed in transfected HEK 293 cells with endogenous receptors present in peripheral blood cells by using the novel radiolabeled receptor antagonist 2029-F20 was used in this work to investigate the presence of A 2B receptors in peripheral blood cells chosen because 1) they represent primary cells expressing endogenous adenosine receptors; 2) they are important inflammatory cells, potentially involved in the exacerbation of asthma and other inflammation conditions; and 3) they contain more than one adenosine receptor subtype and are therefore difficult to study without the availability of selective radioligands. First of all, the presence of A 2B mRNA message in lymphocytes, neutrophils, and monocytes was assessed through realtime RT-PCR assays revealing the presence of A 2B transcript with the following increasing rank order: monocytes Ͻ lymphocytes Ϸ neutrophils. Therefore, the A 2B message was investigated at the protein level by using [
3 H]MRE 2029-F20 binding, which shows a single class of high-affinity binding sites with K D values of 2.4 Ϯ 0.5 and 2.7 Ϯ 0.7 nM and B max values of 79 Ϯ 10 and 54 Ϯ 8 fmol/mg of protein in neutrophils and lymphocytes, respectively. The pharmacological profile of A 2B ligands in these cells confirmed the data obtained in transfected hA 2B HEK 293 cells; MRE 2029-F20 was the most potent compound followed by MRS 1754, AS 100, ZM 241385, and DPCPX. As for agonists, they all confirm a low affinity for the A 2B site. In contrast to mRNA presence of A 2B receptors, in human monocytes it was not possible to detect any specific binding of [ 3 H]MRE 2029-F20, and this is in agreement to findings reported by Thiele et al. (2004) showing an increase of A 2B message in cultured human monocytes in comparison with freshly isolated cells but not A 2B receptor functionality.
In 1999, Linden et al. reported that in transfected HEK 293 cells, A 2B receptors seem to be coupled to adenylyl cyclase and phospholipase C activity; in the same work, coupling to Gq proteins was also observed in HMC-1 cells. However, it is well known that recombinant receptors that are expressed in very high concentrations may produce different coupling in comparison with natural systems in which they are present at a lower level. Therefore, we compared the intracellular signaling pathways regulated by A 2B adenosine receptors in both recombinant systems and native cells. To achieve this, we investigated the regulation of adenylyl cyclase and phospholipase C activity by A 2B receptors, using NECA as the most potent nonselective A 2B agonist available and MRE 2029-F20 as a highly selective A 2B antagonist in HEK 293 cells, neutrophils, and lymphocytes. It is interesting that in the cAMP accumulation assay, NECA exhibited a potency higher than that observed in binding experiments, according to Linden et al. (1999) . Because this effect was not potently reversed by MRE 2029-F20 (IC 50 , 150 nM), we investigated the possible presence of A 2A receptors in these cells. Even though previous studies reported the absence of A 2A transcript and protein in HEK 293 cells (Cooper et al., 1997; Gao et al., 1999) , in our conditions, real-time RT-PCR and binding studies revealed the presence of A 2A receptors (B max of 35 fmol/mg of protein). Therefore, new experiments to determine the potency of MRE 2029-F20 to counteract the NECA-induced cAMP levels were performed in the presence of a fixed concentration of the A 2A blocker SCH 58261. With this experimental approach, the A 2B antagonist showed a pA 2 of 7.8, which was consistent with its binding affinity. The discrepancy between our data and previous data might be related either to a different method used to reveal A 2A receptors or to a different strain of HEK 293 cells. In native cells, the coexpression of all adenosine subtypes coupled to the same effector system makes it impossible to study the contribution of each receptor subtype without the availability of selective ligands. Because of the lack of selectivity of NECA, cAMP accumulation in peripheral blood cells was evaluated by using the same pharmacological approach described above and previously reported in HMC-1 cells (Feoktistov and Biaggioni, 1998) . The stimulatory effect on cAMP levels caused by the A 2A receptor was distinguished from an A 2B effect through the use of SCH 58261 and MRE 2029-F20 as A 2A and A 2B selective antagonists, respectively. Functional A 1 and A 3 subtypes are also present together with A 2A and A 2B in both neutrophils and lymphocytes (Gessi et al., 2002 (Gessi et al., , 2004 . In most cases, a selective blockade of inhibitory adenosine receptors is required to unmask functional stimulatory subtypes (Feoktistov and Biaggioni, 1997) . However, under our conditions, as already reported in various glial cells (Fiebich et al., 1996) , it was not necessary to block A 1 and A 3 receptors to observe either A 2A or A 2B cAMP stimulation. The simultaneous expression of different adenosine subtypes in a single cell is more of a rule than an exception. Because A 2B receptors have low affinity for adenosine it is possible that their role become important in pathologic conditions, when adenosine levels increase. However it has to be noted that other intracellular signaling pathways have been associated with the A 2B stimulation.
In agreement with literature data showing A 2B /Gq coupling in a variety of cells (Feoktistov and Biaggioni, 1995; Strohmeier et al., 1995; Linden et al., 1998 Linden et al., , 1999 Gao et al., 1999; Grant et al., 2001; Feoktistov et al., 2002; Rees et al., 2003) , we also found that A 2B receptors in hA 2B HEK 293 cells activate PLC␤, as demonstrated by inositol phosphate generation and calcium mobilization experiments. NECA induced a significant increase in IP 3 production that was counteracted by the A 2B antagonist MRE 2029-F20 and also by the PLC inhibitor U73122. In calcium mobilization studies, NECA had an EC 50 in the high nanomolar range, in agreement with its affinity in binding experiments, and MRE 2029-F20 was able to potently antagonize this effect. A 2B regulation of intracellular calcium increase was dependent on G q/11 and PLC␤ as demonstrated in experiments carried out in the presence of pertussis toxin and U73122. Stimulation of intracellular calcium levels was not observed in wild-type HEK 293 cells, according to Ryzhov et al. (2004) , but in contrast with Gao et al. (1999) . Again, a different strain of cells might be responsible for these discrepancies, and under our experimental conditions, one could hypothesize that the increase in levels of receptor expression obtained by transfection technique led to a gain in coupling of A 2B receptors to PLC signaling pathway. As for neutrophils, both IP 3 production and calcium increase were observed after 100 M NECA stimulation. Because of the presence of A 3 receptors in human neutrophils that might be coupled to PLC (Gessi et al., 2002) , we verified the role of A 2B receptors in the NECA-induced effect. MRE 2029-F20 reduced both IP 3 production and intracellular calcium increase, showing a potency in the nanomolar range that was consistent with the involvement of the A 2B subtype. The coupling to PLC␤ was not observed in human lymphocytes (Mirabet et al., 1999) , where the amount of A 2B receptors was slightly lower compared with human neutrophils, suggesting that receptor density might be important to establish the signaling pathways activated by receptor agonist stimulation.
In conclusion, in this work, we have demonstrated the presence and functional coupling of human A 2B adenosine receptors in different peripheral blood cells that play a role in immune and inflammatory processes in which A 2B receptors are thought to be involved. This analysis was made possible by [ 3 H]MRE 2029-F20, a new selective and high-affinity antagonist radioligand for human A 2B adenosine receptors that has been successfully employed to detect and quantify the amount of this adenosine subtype in native cells. Our data reveal that recombinant A 2B receptors expressed in HEK 293 cells show binding characteristics similar to those presented by A 2B subtypes expressed in peripheral blood cells but might differ from these in terms of signal transduction coupling as seen in lymphocytes. Further studies might elucidate other effects mediated by A 2B receptors in neutrophils and lymphocytes, such as their involvement in superoxide anion generation or in cytokine release. The appreciation of the pathways activated by A 2B receptors in native cells raises the possibility that selective antagonists may become useful tools for the pharmacological characterization of diseases in which A 2B receptors may be involved and possibly a basis for drug development.
